IMPDH2 and neoplasm: To further investigate whether pharmacological inhibition of IMPDH2 could reverse oxaliplatin resistance in vivo, we established subcutaneous xenograft tumour models by inoculating HCT8/L-OHP cells into the right flank of nude mice.